Patent · US Active

Antibodies targeting B-cell maturation antigen and methods of use

US10562972B2 · kind B2 · utility

7Cited by
9References
67Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2017
Grant dateFeb 18, 2020
Priority date—
Expiry dateJun 5, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70578
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The presently disclosed subject matter provides antibodies that bind to B-cell maturation antigen (BCMA) and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.